Novichok
Novichok (newcomer in English) refers to a group of advanced nerve agents developed by the Soviet Union and later by Russia between the 1970s and 1990s. The Novichok program aimed to create and manufacture highly potent and undetectable chemical weapons.
History[edit]
The Novichok program was part of a Soviet Union initiative known as Foliant. The program was initiated in the 1970s and continued until the 1990s. The main goal of the program was to develop a new class of nerve agents that would be undetectable by NATO's standard detection equipment and would also be safe to handle. The program was highly secretive and was not disclosed to the international community.
Characteristics[edit]
Novichok agents are unique due to their ability to be delivered as binary weapons. This means that they are comprised of two separate components that are harmless on their own, but when combined, they react to produce the toxic agent. This characteristic makes them safer to handle, store, and transport.
Novichok agents are also known for their high toxicity. They are considered to be the deadliest nerve agents ever made, with some variants being five to eight times more potent than VX nerve agent.
Use[edit]
The most notable use of Novichok was in the poisoning of Sergei and Yulia Skripal in 2018 in Salisbury, England. The incident led to a major international scandal, with the UK government accusing Russia of the attack. Russia has denied any involvement.
International response[edit]
The use of Novichok agents is considered a violation of the Chemical Weapons Convention, which prohibits the production, stockpiling, and use of chemical weapons. The international community has condemned the use of Novichok and called for those responsible to be held accountable.
See also[edit]
-
Novichok examples
-
Novichok A230 (Mirzayanov 2009)
-
Novichok Iran 7
-
A-234 (Mirzayanov)
-
Novichok synthesis
-
Novichok detection by LC-HRMSMS
-
Novichok agent formula from Kivelidi case
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
